Comparison of commercial antimicrobial susceptibility test methods for testing of Staphylococcus aureus and Enterococci against vancomycin, daptomycin, and linezolid

J Clin Microbiol. 2014 Jun;52(6):2216-22. doi: 10.1128/JCM.00957-14. Epub 2014 Apr 9.

Abstract

Three commercial antimicrobial susceptibility testing (AST) methods were compared to broth microdilution for testing of Staphylococcus aureus and enterococci against vancomycin, daptomycin, and linezolid. Despite high levels of categorical agreement and essential agreement, vancomycin MICs determined by MicroScan were often 1 log2 concentration higher and MICs determined by Phoenix 1 log2 concentration lower. Daptomycin MICs were 1 to 2 log2 concentrations higher by all AST methods, except Etest, potentially impacting definitive antimicrobial therapy for bloodstream infections due to these organisms.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Daptomycin / pharmacology
  • Enterococcus / drug effects*
  • Humans
  • Linezolid
  • Microbial Sensitivity Tests / methods*
  • Oxazolidinones / pharmacology
  • Staphylococcus aureus / drug effects*
  • Vancomycin / pharmacology

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Oxazolidinones
  • Vancomycin
  • Linezolid
  • Daptomycin